CVE-2023-39537

Name: CVE-2023-39537
Creator: NVD / NIST
Published: 2023-11-14T22:15:29.923+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

HIGHCVSS 7.8/10EPSS 0.21%

Last modified Jun 17, 2026

CVE-2023-39537 is a high-severity vulnerability rated 7.8/10 on the CVSS scale. AMI AptioV contains a vulnerability in BIOS where an Attacker may use an improper input validation via the local network. A successful exploit of this vulnerability may lead to a loss of confidentiality, integrity and availability.. EPSS estimates a 0.21% chance of exploitation in the next 30 days.

Description

AMI AptioV contains a vulnerability in BIOS where an Attacker may use an improper input validation via the local network. A successful exploit of this vulnerability may lead to a loss of confidentiality, integrity and availability.

Metrics

CVSS 3.1

7.8/10

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

0.21%

10.7th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-20

Affected Software

Vendor	Product	Versions
Ami	Aptio V	All versions

References

Timeline

Published: Nov 14, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-39537?

How severe is CVE-2023-39537?

CVE-2023-39537 has a CVSS score of 7.8/10 (HIGH severity). The EPSS model estimates a 0.21% probability of exploitation in the next 30 days.

How do I fix CVE-2023-39537?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-39537?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST